/ /

  • linkedin
  • Increase Font
  • Sharebar

    Binkhorst Lecture: Right time for MIGS

    Boston—Interventional glaucoma is the new horizon for patients. Microinvasive glaucoma surgery (MIGS)—a term coined by Iqbal Ike K. Ahmed, MD—will allow for early intervention in patients with glaucoma and be safe and more effective than the medications and laser procedures used for so long with less efficacy.

    In his delivery of the Binkhorst Lecture during the ASCRS Opening General Session, Dr. Ahmed—assistant professor, University of Toronto and clinical assistant professor, University of Utah, Salt Lake City—described the work in progress with various glaucoma devices, whose designs are still evolving.

    With the realization that phacoemulsification lowered IOP, the cataract procedure was combined with a trabecular micro-bypass device (iStent, Glaukos) to explore the duration of the effect of phacoemulsification compared with combined phacoemulsification and the stent. The results indicated that the device effectively lowered the number of medications that patients required after surgery.

    MIGS research, Dr. Ahmed continued, is thinking outside the box and finding ingenious ways to access aqueous outflow. One of which is gonioscopic targeting of aqueous veins—which Dr. Ahmed referred to as “superhighways”—to determine where to place stents to re-establish aqueous outflow in damaged veins.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results